Dergi makalesi Açık Erişim

Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-kappa B activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells

2019    Coker-Gurkan, Ajda; Bulut, Derya; Genc, Recep; Arisan, Elif-Damla; Obakan-Yerlikaya, Pinar; Palavan-Unsal, Narcin

Autocrine growth hormone (GH) signaling is a promoting factor for breast cancer via triggering abnormal cell growth, proliferation, and metastasis, drug resistance. Curcumin (diferuloylmethane), a polyphenol derived from turmeric (Curcuma longa), has anti-proliferative, anti-carcinogenic, anti-hormonal effect via acting on PI3K/Akt, NF-kappa B and JAK/STAT signaling. Forced GH expression induced epithelial mesenchymal transition (EMT) through stimulation of miR-182-96-183 cluster expression in breast cancer cells. This study aimed to investigate the role of NF-kappa B signaling and miR-182-96-183 cluster expression profile on autocrine GH-mediated curcumin resistance, which was prevented by time-dependent curcumin treatment in T47D breast cancer cells. Dose- and time-dependent effect of curcumin on T47D wt and GH+breast cancer cells were evaluated by MTT cell viability and trypan blue assay. Apoptotic effect of curcumin was determined by PI and Annexin V/PI FACS flow analysis. Immunoblotting performed to investigate the effect of curcumin on PI3K/Akt/MAPK, NF-kappa B signaling. miR182-96-183 cluster expression profile was observed by qRT-PCR. Overexpression of GH triggered resistant profile against curcumin (20 mu M) treatment for 24h, but this resistance was accomplished following 48h curcumin exposure. Concomitantly, forced GH induced invasion and metastasis through EMT and NF-kappa B activation were prevented by long-term curcumin exposure in T47D cells. Moreover, 48h curcumin treatment prevented the autocrine GH-mediated miR-182-96-183 cluster expression stimulation in T47D cells. In consequence, curcumin treatment for 48h, prevented autocrine GH-triggered invasion-metastasis, EMT activation through inhibiting NF-kappa B signaling and miR-182-96-183 cluster expression and induced apoptotic cell death by modulating Bcl-2 family members in T47D breast cancer cells.